Enhancement of viral infectivity with DEAE-dextran: application to development of vaccines.
D000818:Animals; D002460:Cell Line; D046508:Culture Techniques; D004279:DNA, Viral; D003911:Dextrans / Q000494:pharmacology*; D005021:Ethylamines / Q000494:pharmacology*; D000882:Haplorhini; D006493:Heparin / Q000494:pharmacology; D007668:Kidney; D008970:Molecular Weight; D010636:Phenols / Q000494:pharmacology; D017955:Poliovirus / Q000276:immunology; D012367:RNA, Viral; D013539:Simian virus 40 / Q000276:immunology; D014765:Viral Vaccines; D014779:Virus Replication; D014780:Viruses / Q000472:pathogenicity*
D004279:DNA, Viral; D003911:Dextrans; D005021:Ethylamines; D010636:Phenols; D012367:RNA, Viral; D014765:Viral Vaccines; D006493:Heparin